Dr. Felix Weiland is a pharmacist by training with a PhD in pharmacology. In 2006, he joined Boehringer Ingelheim as a trainee, focusing on launch and transfer activities of inhalative products. He took over different roles in the field of device development, project management and related QA aspects. In 2010 he joined the Gerresheimer Group at Bünde as a QC head and later quality director. Buende is a large-scale manufacturing site of sterile primary packaging components, i.e.RTF®- syringes and insulin cartridges. In 2015, he returned to Boehringer Ingelheim microParts in Dortmund to implement structures for systematic life cycle management of the Respimat® Platform Technology, including development and launch of the Respimat Reusable Soft Mist Inhaler.
Currently he is the director of device technology in Operations. This includes responsibilities for project management, design verification laboratories, process design, design control and prototyping of transfered drug delivery devices during the life cycle.